{"id":955,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2003-12-18","marketCap":40.11039733886719,"name":"MEI Pharma Inc","phone":"18587926300.0","outstanding":6.659999847412109,"symbol":"MEIP","website":"https://www.meipharma.com/","industry":"Biotechnology"},"price":6.093725,"year":2023,"month":11,"day":18,"weekday":"Saturday","title":"Historical Performance of MEI Pharma Inc Stock During Economic Recessions and Recoveries","date":"2023-11-18","url":"/posts/2023/11/18/MEIP","content":[{"section":"Introduction","text":"MEI Pharma Inc is a biopharmaceutical company that develops novel therapies for cancer. To evaluate its performance during economic recessions and recoveries, historical stock price data will be analyzed."},{"section":"Data Collection","text":"Historical stock price data for MEI Pharma Inc will be collected from reliable financial sources, such as financial data providers, stock exchanges, or third-party analysis platforms. This data will cover periods of economic recessions and recoveries."},{"section":"Analysis of Economic Recessions","text":"The stock performance of MEI Pharma Inc during economic recessions will be analyzed by comparing its stock price trends with the overall market trends. The analysis will consider the impact of broader economic factors and investor sentiment on the stock's performance."},{"section":"Analysis of Economic Recoveries","text":"The stock performance of MEI Pharma Inc during economic recoveries will be analyzed to assess its ability to rebound and take advantage of improving market conditions. The analysis will consider factors such as company-specific developments, industry trends, and overall market performance."},{"section":"Comparison with Benchmarks","text":"The analysis will also compare the performance of MEI Pharma Inc stock with relevant market benchmarks, such as the S\u0026P 500 or sector-specific indices, during economic recessions and recoveries. This will help provide context and gauge the stock's relative performance."},{"section":"Limitations","text":"It is important to note that past performance is not indicative of future results. Additionally, the analysis may be limited by factors such as data availability, accuracy, and the influence of extraneous variables on stock performance."},{"section":"Conclusion","text":"By objectively analyzing the historical performance of MEI Pharma Inc stock during economic recessions and recoveries, this analysis aims to provide insights into its resilience and potential opportunities for growth during challenging economic periods."}],"tags":["CrossOver100","Long","Biotechnology"],"news":[{"category":"company","date":1700226360,"headline":"AstraZeneca's (AZN) Capivasertib Gets FDA Nod for Breast Cancer","id":123947928,"image":"https://media.zenfs.com/en/zacks.com/17664ed95646b97db9beb170298a16b3","symbol":"MEIP","publisher":"Yahoo","summary":"AstraZeneca's (AZN) capivasertib gets approval in combination with Faslodex for HR-positive, HER2-negative metastatic breast cancer.","url":"https://finance.yahoo.com/news/astrazenecas-azn-capivasertib-gets-fda-130600879.html"},{"category":"company","date":1700134380,"headline":"12 Health Care Stocks Moving In Thursday's Intraday Session","id":123924833,"image":"","symbol":"MEIP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3215950568"},{"category":"company","date":1700118780,"headline":"12 Health Care Stocks Moving In Thursday's Pre-Market Session","id":123921241,"image":"","symbol":"MEIP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3215613409"},{"category":"company","date":1699949160,"headline":"Stifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)","id":123905489,"image":"","symbol":"MEIP","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3213027265"},{"category":"company","date":1699632540,"headline":"Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises","id":123791835,"image":"https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6","symbol":"MEIP","publisher":"Yahoo","summary":"Ironwood's (IRWD) third-quarter 2023 earnings miss estimates, while revenues beat the same. Linzess collaboration revenues drive the top line.","url":"https://finance.yahoo.com/news/ironwoods-irwd-q3-earnings-miss-160900318.html"},{"category":"company","date":1699563900,"headline":"MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights","id":123774066,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"MEIP","publisher":"Yahoo","summary":"SAN DIEGO, November 09, 2023--MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today reported results for the quarter ended September 30, 2023 and highlighted recent corporate events.","url":"https://finance.yahoo.com/news/mei-pharma-reports-first-quarter-210500033.html"},{"category":"company","date":1699552920,"headline":"Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated","id":123765009,"image":"https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307","symbol":"MEIP","publisher":"Yahoo","summary":"Amicus (FOLD) incurs a narrower-than-expected loss in the third quarter. However, revenues beat estimates. The company tightens Galafold revenue guidance for 2023.","url":"https://finance.yahoo.com/news/amicus-fold-q3-loss-narrows-180200825.html"},{"category":"company","date":1699505040,"headline":"MEI Pharma GAAP EPS of $8.46, revenue of $65.3M","id":123765558,"image":"","symbol":"MEIP","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3205047779"},{"category":"company","date":1699448400,"headline":"MEI Pharma to Present at the Stifel 2023 Healthcare Conference","id":123737546,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"MEIP","publisher":"Yahoo","summary":"SAN DIEGO, November 08, 2023--MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced it will participate in the Stifel 2023 Healthcare Conference. David Urso, president and chief executive officer, will present a company overview and business update on Wednesday, November 15 at 8:35 AM Eastern Time.","url":"https://finance.yahoo.com/news/mei-pharma-present-stifel-2023-130000736.html"},{"category":"company","date":1699372920,"headline":"Axsome (AXSM) Q3 Loss Widens, Revenues Surpass Estimates","id":123692151,"image":"https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307","symbol":"MEIP","publisher":"Yahoo","summary":"Axsome (AXSM) incurs a wider-than-expected loss in the third quarter of 2023 while sales beat estimates. The company's shares declined post earnings announcement.","url":"https://finance.yahoo.com/news/axsome-axsm-q3-loss-widens-160200430.html"},{"category":"company","date":1699307820,"headline":"MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock","id":123676131,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"MEIP","publisher":"Yahoo","summary":"SAN DIEGO, November 06, 2023--MEI Pharma, Inc. (Nasdaq: MEIP) (the \"Company\"), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that pursuant to the previously disclosed cooperation agreement with Anson Funds and Cable Car Capital, the Companyâ€™s Board of Directors today declared a special cash dividend (the \"Dividend\") of $1.75 per share of common stock, $0.00000002 par value, payable on December 6, 2023 to stockholders of record at the close","url":"https://finance.yahoo.com/news/mei-pharma-declares-special-cash-215700853.html"},{"category":"company","date":1699243740,"headline":"MEI Pharma declares $1.75 dividend","id":123710478,"image":"","symbol":"MEIP","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3198355018"},{"category":"company","date":1699243140,"headline":"MEI Pharma declares special cash dividend of $1.75 per share","id":123710479,"image":"","symbol":"MEIP","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3198335582"}]}